Financials Touyun Biotech Group Limited

Equities

1332

BMG8962M1038

Non-Paper Containers & Packaging

Market Closed - Hong Kong S.E. 01:38:13 03/07/2024 pm IST 5-day change 1st Jan Change
0.17 HKD -5.56% Intraday chart for Touyun Biotech Group Limited -5.56% -26.09%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,323 551.1 2,080 3,704 1,207 645.4
Enterprise Value (EV) 1 1,415 606.3 2,140 4,015 1,558 1,100
P/E ratio -5.21 x -2.75 x -11.9 x -50.6 x -6.09 x -2.4 x
Yield - - - - - -
Capitalization / Revenue 3.79 x 1.61 x 10.1 x 13.1 x 3.82 x 3.25 x
EV / Revenue 4.06 x 1.77 x 10.3 x 14.2 x 4.93 x 5.54 x
EV / EBITDA -11.4 x -21.2 x -42.8 x -117 x -51.5 x -15.4 x
EV / FCF -5.08 x 4.58 x -11.8 x -45.1 x -39.1 x -1,698 x
FCF Yield -19.7% 21.8% -8.47% -2.22% -2.56% -0.06%
Price to Book 1.82 x 1.02 x 4.26 x 7.88 x 4.57 x -762 x
Nbr of stocks (in thousands) 24,49,328 24,49,328 27,73,652 28,05,952 28,05,952 28,05,952
Reference price 2 0.5400 0.2250 0.7500 1.320 0.4300 0.2300
Announcement Date 18/04/19 28/04/20 13/04/21 28/04/22 27/04/23 29/04/24
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 348.8 342.7 206.8 283.5 315.8 198.6
EBITDA 1 -123.6 -28.64 -49.94 -34.44 -30.24 -71.41
EBIT 1 -144.7 -36.24 -54.86 -38.15 -42.46 -90.15
Operating Margin -41.48% -10.57% -26.53% -13.46% -13.45% -45.39%
Earnings before Tax (EBT) 1 -252 -194.9 -172 -123 -199.2 -272.6
Net income 1 -253.9 -200.5 -168.8 -72.95 -198.1 -268.9
Net margin -72.79% -58.51% -81.62% -25.73% -62.71% -135.39%
EPS 2 -0.1037 -0.0819 -0.0632 -0.0261 -0.0706 -0.0958
Free Cash Flow 1 -278.7 132.3 -181.1 -89.05 -39.85 -0.6476
FCF margin -79.92% 38.62% -87.59% -31.41% -12.62% -0.33%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18/04/19 28/04/20 13/04/21 28/04/22 27/04/23 29/04/24
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 92 55.2 59.3 312 351 454
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.7443 x -1.926 x -1.187 x -9.045 x -11.61 x -6.363 x
Free Cash Flow 1 -279 132 -181 -89 -39.8 -0.65
ROE (net income / shareholders' equity) -30.1% -31.3% -31.2% -23.8% -52.6% -179%
ROA (Net income/ Total Assets) -7.56% -2.35% -3.69% -2.39% -2.78% -7.54%
Assets 1 3,358 8,544 4,574 3,054 7,136 3,568
Book Value Per Share 2 0.3000 0.2200 0.1800 0.1700 0.0900 -0
Cash Flow per Share 2 0.0400 0.0200 0.0500 0.0200 0.0500 0.0100
Capex 1 27.4 3.66 126 164 12.9 17.1
Capex / Sales 7.84% 1.07% 60.7% 57.67% 4.09% 8.63%
Announcement Date 18/04/19 28/04/20 13/04/21 28/04/22 27/04/23 29/04/24
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 1332 Stock
  4. Financials Touyun Biotech Group Limited